泰林生物: 第四届董事会第八次会议决议公告

Group 1 - The board of directors of Zhejiang Tailin Biological Technology Co., Ltd. held its eighth meeting of the fourth session on June 13, 2025, which was legally and effectively convened [1] - The board approved the proposal to elect Li Guowei as an independent director candidate, who will also serve as the chairman of the audit committee, a member of the nomination committee, and a member of the compensation and assessment committee upon approval by the shareholders' meeting [1][2] - The board approved the proposal to increase capital for its wholly-owned subsidiary, Zhejiang Tailin New Materials Co., Ltd., using surplus raised funds amounting to 109.3688 million yuan, with 90 million yuan allocated to registered capital [2][3] Group 2 - The board proposed to hold the second extraordinary general meeting of shareholders on June 30, 2025, at 14:00 [3]